(SPTM) Portfolio S&P 1500 - Overview
Etf: Large-Cap, Mid-Cap, Small-Cap, Equity
Dividends
| Dividend Yield | 1.23% |
| Yield on Cost 5y | 2.07% |
| Yield CAGR 5y | 6.39% |
| Payout Consistency | 97.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.2% |
| Relative Tail Risk | 4.47% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.63 |
| Alpha | 0.32 |
| Character TTM | |
|---|---|
| Beta | 0.958 |
| Beta Downside | 0.965 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.87% |
| CAGR/Max DD | 1.08 |
Description: SPTM Portfolio S&P 1500 January 02, 2026
SPTM is a U.S.-based ETF that aims to replicate the combined performance of the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices, thereby covering large-, mid-, and small-cap stocks. By policy, the fund must hold at least 80 % of its net assets in the constituent securities of these three indices, effectively delivering near-full exposure to the broad U.S. equity market.
Key metrics (as of the most recent quarterly filing, Q4 2025) include an expense ratio of 0.04 %, total assets under management of roughly $5.2 billion, and a 30-day SEC yield of 1.45 %. The ETF’s sector weights closely track the overall market, with information technology (~27 %) and health care (~14 %) as the two largest exposures-both sectors that have historically driven U.S. earnings growth. Macro-level drivers such as U.S. GDP growth (≈2.5 % annualized) and the Federal Reserve’s policy rate (currently 5.25 %) are primary determinants of the fund’s performance, given their impact on corporate earnings and valuation multiples across market caps.
For a deeper, data-rich analysis of SPTM’s risk-adjusted returns and how it fits into a diversified portfolio, you might explore the detailed analytics available on ValueRay.
What is the price of SPTM shares?
Over the past week, the price has changed by +0.21%, over one month by +0.23%, over three months by +4.04% and over the past year by +15.12%.
Is SPTM a buy, sell or hold?
What are the forecasts/targets for the SPTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 98.8 | 17.6% |
SPTM Fundamental Data Overview February 03, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 12.04b USD (12.04b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 12.04b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 12.04b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.44% (E(12.04b)/V(12.04b) * Re(9.44%) + (debt-free company))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)